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Abstract
The selective functionalization of peptides containing only natural amino acids is important for the modification of biomolecules. In
particular, the installation of an alkyne as a useful handle for bioconjugation is highly attractive, but the use of a carbon linker is
usually required. Herein, we report the gold-catalyzed direct alkynylation of tryptophan in peptides using the hypervalent iodine
reagent TIPS-EBX (1-[(triisopropylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one). The reaction proceeded in 50–78% yield under mild
conditions and could be applied to peptides containing other nucleophilic and aromatic amino acids, such as serine, phenylalanine
or tyrosine.
Introduction
Alkynes have always been important building blocks in synthe-
tic organic chemistry. Recently, they have attracted also strong
interest for applications in materials science and chemical
biology [1]. One of the most important transformations of
alkynes is the copper-catalyzed [3 + 2] cycloaddition with
azides, which can be performed under mild conditions in the
presence of multiple functional groups, and has therefore found
broad applications for the modification of biomolecules and
polymers [2-5]. But before the unique reactivity of the triple
bond can be unravelled, it is necessary to introduce it onto the
desired molecules. In this context, the modification of natural
peptides and proteins is highly attractive, and it has been the
target of intensive research in the last decades (Figure 1) [6-11].
The functionalization of highly reactive cysteine, lysine and the
N-terminus has been particularly successful [12-17], whereas
the more challenging modification of the electron-rich aromatic
residues of tyrosine [18-20] and tryptophan [21-31] has been
the focus of recent interest. As tryptophan is a rare amino acid,
its functionalization is especially interesting. It has been
achieved in the past for example by Francis and co-workers and
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Ball and co-workers using rhodium-catalyzed carbene-insertion
reactions [21-23] or via direct C–H arylation [24-29]. If the
installation of alkynes on peptides or proteins is desired, an
indirect method using a linker is used, for example an alkyl-
ation reaction of cysteine. The direct introduction of an alkyne
onto the biomolecule would be interesting to profit from modi-
fied electronic and spectroscopic properties. However, the
direct alkynylation of peptides or proteins is usually based on
the use of the Sonogashira reaction, which requires modified
non-natural amino acids [32,33].
Figure 1: Functionalization of natural peptides and proteins: state of
the art.
In 2013, our group reported the alkynylation of thiols using the
hypervalent iodine reagent TIPS-EBX (1a, 1-[(triisopropyl-
silyl)ethynyl]-1,2-benziodoxol-3(1H)-one) (Scheme 1A) [34].
The reaction was almost instantaneous. It was highly chemose-
lective for thiols in the presence of other nucleophilic func-
tional groups. The alkynylation could be therefore applied to
cysteine-containing peptides. The scope of the reaction could be
later extended to a broad range of aliphatic and aromatic
alkynes [35]. In 2015, the efficiency of the reaction for the
functionalization of proteins both in cell lysates and in the
living cell was finally demonstrated [36].
Even if the alkynylation of cysteines is an important method,
thiols are often part of disulfide bonds in folded proteins, and
therefore difficult to access. Reduction and unfolding, or pro-
tein engineering to install more accessible cysteines, are usually
required. For these reasons, it is important to develop selective
alkynylation methods in order to functionalize other amino
acids. The direct C–H functionalization of aromatic compounds
is an attractive method for the modification of biomolecules
without the need for non-natural amino acids. However, the
multiple functional groups present in biomolecules make such a
process highly challenging. Based on our previous work on the
alkynylation of indoles using TIPS-EBX (1a) and a gold cataly-
sis [37,38], we wondered if this transformation could be extend-
Scheme 1: Alkynylation with EBX reagents.
ed to tryptophan-containing peptides. Even if the reaction gave
C3-alkynylation for C3-unsubstituted indoles, we demonstrated
that C2-alkynylation could be achieved on skatole (2a,
Scheme 1B) [37]. Very recently, Hansen et al. indeed reported a
modified protocol using a gold catalyst and TIPS-EBX (1a) for
the alkynylation of tryptophan-containing peptides and even
proteins (Scheme 1C) [39]. This recent disclosure motivated us
to report our own work on this transformation, resulting in an
efficient direct alkynylation of tryptophan-containing peptides.
Results and Discussion
We started our investigation by attempting the alkynylation of
valine-tryptophan dipeptide 4a as model substrate (Table 1). An
often used carboxybenzyl (Cbz, Z) protecting group was
chosen. Examining this substrate will tell if C2-alkynylation is
possible in the presence of an ester, a carbamate and an amide
protecting group. A promising result was obtained with
5 mol % gold chloride as catalyst at room temperature in aceto-
nitrile (Table 1, entry 1). Although the reaction did not go to
completion even after two days, the desired C2 alkynylation
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product 5a was obtained in 44% yield. The yield could be in-
creased to 72% when the reaction was performed at 40 °C (Ta-
ble 1, entry 2). No further improvement was observed at higher
temperature (Table 1, entry 3). The product 5a could also be ob-
tained in a broad range of other solvents, as long as the solu-
bility of the substrate 4a and TIPS-EBX (1a) was sufficient (Ta-
ble 1, entries 4–8). The best yield was obtained in acetonitrile
(Table 1, entry 2). Although the presence of water slowed down
the reaction, the desired product could still be obtained in 41%
yield (Table 1, entry 9). Monitoring the reaction over time
showed that 34% of product 5a was already formed after 20
min (Table 1, entry 10), but the reaction then slowed down sig-
nificantly, with 67% yield after 10 h and 78% after 24 h
(Table 1, entries 11 and 12). At this point, a conversion higher
than 90% was achieved, with no significant improvement after a
longer reaction time.
Table 1: Optimization of the alkynylation of dipeptide 4a.
entry solvent time (h) T (°C) yielda
1 CH3CN 48 23 44%
2 CH3CN 48 40 72%
3 CH3CN 48 60 67%
4 iPrOH 48 40 60%
5 MeOH 48 40 50%
6 acetone 48 40 39%
7 CH2Cl2 48 40 63%
8 DMSO 48 40 38%
9 CH3CN
5% H2O
48 40 41%
10 CH3CN 0.3 40 34%
11 CH3CN 10 40 67%
12 CH3CN 24 40 78%
aReaction conditions: 0.20 mmol 4a, 0.24 mmol TIPS-EBX (1a),
0.010 mmol AuCl in 2 mL solvent were stirred at the indicated temper-
ature and time. Isolated yields after column chromatography are given.
With the optimized conditions in hand, we investigated the
scope of the reaction with different amino acids in the dipep-
tide (Scheme 2). With glycine as second amino acid, the desired
product 5b could be obtained in 66% yield. The reaction was
selective for tryptophan in the presence of other aromatic amino
acids, such as phenylalanine or tyrosine (products 5c and 5d).
Serine and proline containing dipeptides 5e and 5f could also be
obtained in 64% and 53% yield, respectively. The reaction was
therefore general for dipeptides bearing tryptophan at the
C-terminus. On the other hand, only traces of alkynylated
dipeptide 5g with a tryptophan at the N-terminus could be ob-
tained under these reaction conditions. A first example of
valine–tryptophan–valine tripeptide was also examined, and
product 5h was isolated in 50% yield, demonstrating that
alkynylation of tryptophan inside a peptide chain was possible.
Unfortunately, only limited conversion was observed with N- or
C-terminus unprotected peptides. Nevertheless, Hansen and
co-workers recently demonstrated that N- and C-termini unpro-
tected peptides, as well as more complex peptides and even pro-
teins, could be alkynylated using modified reaction conditions
(10 mol % AuCl(SMe2), three equivalents TIPS-EBX (1a) and
2 mol % trifluoroacetic acid as co-catalyst) [39]. They also
demonstrated that the obtained silylalkyne products can be
easily deprotected with fluoride sources to allow bioconjuga-
tion via cycloaddition with azides.
Conclusion
In conclusion, our work combined with the results of Hansen
and co-workers has demonstrated that the gold-catalyzed
alkynylation of indoles could be extended to tryptophan in
peptides. When considering the scarcity of methods allowing
the modification of tryptophan under mild conditions without
requiring the installation of non-natural amino acids, the trans-
formation will be highly useful for bioconjugation. A current
limitation of the developed alkynylation reaction is the require-
ment for organic solvents. Investigations are currently ongoing
in our laboratory for the development of water-compatible
reagents and catalysts.
Experimental
General procedure for the gold-catalyzed
alkynylation
The starting peptide 4 (0.20 mmol, 1 equiv) and TIPS-EBX (1a,
0.240 mmol, 103 mg, 1.2 equiv) were added into a 5 mL test
tube equipped with a stirring bar. Acetonitrile (2 mL) was
added, then the reaction mixture was stirred at 40 °C for 2 min.
Gold(I) chloride (2.3 mg, 10 µmol, 0.05 equiv) was added in
one portion. The reaction tube was sealed and stirring was
continued for 24 h at 40 °C. Afterwards, the mixture was
diluted with EtOAc (50 mL), and the organic layer was washed
with a mixture of water (2.5 mL) and conc. NaHCO3 solution
(2.5 mL), and then with brine (20 mL), and dried over MgSO4.
The solvent was evaporated under reduced pressure and the re-
sulting yellow oil was purified by column chromatography
(SiO2, hexane/EtOAc 3:1 to 2:3). The product was dried under
reduced pressure, and washed into a vial with Et2O. The sol-
vent was evaporated under vacuum and dried under high
vacuum (ca. 10−2 mbar) for several hours.
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Scheme 2: Alkynylation of tryptophan-containing peptides.
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1. General Methods 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, unless 
stated otherwise. For quantitative flash chromatography technical grade solvents were used. For 
flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were used. THF, 
Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated alumina under 
nitrogen atmosphere (H2O content < 10 ppm, Karl-Fischer titration). All chemicals were 
purchased from Acros, Aldrich, Fluka, VWR, Aplichem or Merck and used as such unless stated 
otherwise. Chromatographic purification was performed as flash chromatography using 
Macherey-Nagel silica 40-63, 60 Å, using the solvents indicated as eluent with 0.1-0.5 bar 
pressure. TLC was performed on Merck silica gel 60 F254 TLC glass plates or aluminium plates 
and visualized with UV light, permanganate stain, CAN stain or Anisaldehyde stain. Melting 
points were measured on a calibrated Büchi B-540 melting point apparatus using open glass 
capillaries. 1H-NMR spectra were recorded on a Brucker DPX-400 400 MHz spectrometer in 
chloroform-d, DMSO-d6 or CD3OD, all signals are reported in ppm with the internal chloroform 
signal at 7.26 ppm or the internal DMSO signal at 2.50 ppm as standard. The data is being 
reported as (s = singlet, d = doublet, t = triplet, q = quadruplet, qi = quintet, m = multiplet or 
unresolved, br = broad signal, app = apparent, coupling constant(s) in Hz, integration, 
interpretation).13C-NMR spectra were recorded with 1H-decoupling on a Brucker DPX-400 100 
MHz spectrometer in chloroform-d, DMSO-d6, all signals are reported in ppm with the internal 
chloroform signal at 77.0 ppm, the internal DMSO signal at 39.5 ppm. Infrared spectra were 
recorded on a JASCO FT-IR B4100 spectrophotometer with an ATR PRO410-S and a ZnSe 
prisma and are reported as cm-1 (w = weak, m = medium, s = strong, br = broad). High 
resolution mass spectrometric measurements were performed by the mass spectrometry service of 
ISIC at the EPFL on a MICROMASS (ESI) Q-TOF Ultima API.  
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2. Preparation of TIPS-EBX (1a)  
The synthesis of TIPS-EBX (1a) has been already described before. The procedures are taken 
here from the indicated publications to facilitate reproduction of the results by having all the data 
in the same file. This reagent is also commercially available. 
1-Hydroxy-1,2-benziodoxol-3-(1H)-one (7) 
 
Following a reported procedure,1 NaIO4 (7.24 g, 33.8 mmol, 1.05 equiv) and 2-iodobenzoic acid 
(6) (8.00 g, 32.2 mmol, 1.00 equiv) were suspended in 30% (v/v) aq. AcOH (48 mL). The 
mixture was vigorously stirred and refluxed for 4 h. The reaction mixture was then diluted with 
cold water (180 mL) and allowed to cool to room temperature, protecting it from light. After 1 h, 
the crude product was collected by filtration, washed on the filter with ice cold water (3 x 20 mL) 
and acetone (3 x 20 mL), and air-dried in the dark to give the pure product 7 (8.3 g, 31 mmol, 
98%) as a white solid. 1H NMR (400 MHz, (CD3)2SO): δ 8.02 (dd, J = 7.7, 1.4 Hz, 1H, ArH), 
7.97 (m, 1H, ArH), 7.85 (dd, J = 8.2, 0.7 Hz, 1H, ArH), 7.71 (td, J = 7.6, 1.2 Hz, 1H, ArH); 13C 
NMR (100 MHz, (CD3)2SO): δ 167.7, 134.5, 131.5, 131.1, 130.4, 126.3, 120.4; IR ν 3083 (w), 
3060 (w), 2867 (w), 2402 (w), 1601 (m), 1585 (m), 1564 (m), 1440 (m), 1338 (s), 1302 (m), 1148 
(m), 1018 (w), 834 (m), 798 (w), 740 (s), 694 (s), 674 (m), 649 (m). The values of the NMR 
spectra are in accordance with reported literature data.1 
Triisopropylsilyl trimethylsilylacetylene (9) 
 
Following a reported procedure,2 nBuLi (2.5 M in hexanes, 12.0 mL, 29.9 mmol, 0.98 equiv) was 
added dropwise to a stirred solution of ethynyltrimethylsilane (8) (3.0 g, 30 mmol, 1.0 equiv) in 
                                                          
1 Kraszkiewicz, L.; Skulski, L. Αrkivoc 2003, 6, 120. 
2 Helal, C. J.; Magriotis, P. A.; Corey, E. J. J. Am. Chem. Soc. 1996, 118, 10938. 
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THF (48 mL) at -78 °C. The mixture was then warmed to 0 °C and stirred for 5 min. The mixture 
was then cooled back to -78 °C and chlorotriisopropylsilane (6.4 mL, 30 mmol, 1.0 equiv) was 
added dropwise. The mixture was then allowed to warm to room temperature and stirred 
overnight. A saturated solution of ammonium chloride (40 mL) was added, and the reaction 
mixture was extracted with diethyl ether (2 x 60 mL). The organic layer was washed with water 
and brine, then dried over MgSO4, filtered and concentrated under reduced pressure to obtain a 
colorless liquid which was further purified by Kugelrohr distillation (56-57 °C/0.25 mm of Hg) to 
yield 9 (7.16 g, 28.0 mmol, 92% yield) as a colorless liquid. 1H NMR (400 MHz, CDCl3): δ 1.08 
(m, 21H, TIPS), 0.18 (s, 9H, TMS); IR ν 2959 (m), 2944 (m), 2896 (w), 2867 (m), 1464 (w), 
1385 (w), 1250 (m), 996 (w), 842 (s), 764 (s), 675 (m), 660 (m). The values of the NMR spectra 
are in accordance with reported literature data.2 
1-[(Triiso-propylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one (1a) 
 
Following a reported procedure,3 2-iodosylbenzoic acid (7) (21.7 g, 82.0 mmol, 1.00 equiv) was 
charged in oven-dried three-neck 1L flask equipped with a magnetic stirrer. After 3 
vacuum/nitrogen cycles, anhydrous acetonitrile (500 mL) was added via canula and cooled to 0 
°C. Trimethylsilyltriflate (16.4 mL, 90.0 mmol, 1.10 equiv) was added dropwise via a dropping 
funnel over 30 min (no temperature increase was observed). After 15 min, 
(trimethylsilyl)(triisopropylsilyl)acetylene (9) (23.0 g, 90.0 mmol, 1.10 equiv) was added via 
canula over 15 min (no temperature increase was observed). After 30 min, the suspension became 
an orange solution. After 10 min, pyridine (7.0 mL, 90 mmol, 1.1 equiv) was added via syringe. 
After 15 min, the reaction mixture was transferred in a one-neck 1L flask and reduced under 
vacuum until a solid was obtained. The solid was dissolved in CH2Cl2 (200 mL) and transferred 
in a 1L separatory funnel. The organic layer was washed with 1 M HCl (200 mL) and the 
aqueous layer was back-extracted with CH2Cl2 (200 mL). The organic layers were combined, 
washed with a saturated solution of NaHCO3 (2 x 200 mL), dried over MgSO4, filtered and the 
solvent was evaporated under reduced pressure. Recrystallization from acetonitrile (ca 120 mL) 
                                                          
3 Brand, J. P.; Waser, J. Angew. Chem., Int. Ed. 2010, 49, 7304. 
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afforded 1a (30.1 g, 70.2 mmol, 86%) as colorless crystals. Mp (Dec.): 170-176 °C; 1H NMR 
(400 MHz, CDCl3): δ 8.44 (m, 1H, ArH), 8.29 (m, 1H, ArH), 7.77 (m, 2H, ArH), 1.16 (m, 21H, 
TIPS); 13C NMR (100 MHz, CDCl3): δ 166.4, 134.6, 132.3, 131.4, 131.4, 126.1, 115.6, 114.1, 
64.6, 18.4, 11.1; IR ν 2943 (m), 2865 (m), 1716 (m), 1618 (m), 1604 (s), 1584 (m), 1557 (m), 
1465 (m), 1439 (w), 1349 (m), 1291 (m), 1270 (w), 1244 (m), 1140 (m), 1016 (m), 999 (m), 883 
(m), 833 (m), 742 (m), 702 (s), 636 (m). The values of the NMR spectra are in accordance with 
reported literature data.3 
S6 
 
 
3. Preparation of peptides 
(S)-Methyl 2-amino-3-(1H-indol-3-yl)propanoate (11) 
 
Tryptophan methyl ester hydrochloride (10) (22 mmol, 5.6 g, 1 equiv.) was dissolved in water 
(25 mL). K2CO3 (4.56 g, 33.0 mmol, 1.5 equiv.) was added and the reaction mixture was stirred 
for 15 min. The mixture was extracted with Et2O (3 x 100 mL). The organic layers were 
combined, and dried over Na2SO4 and evaporated under reduced pressure to give a colorless oil. 
The product was then used immediately without further purification. 
(S)-Methyl 2-((S)-2-(((benzyloxy)carbonyl)amino)-3-methylbutanamido)-3-(1H-indol-3-
yl)propanoate (4a) 
 
Following a modification of a reported procedure,4 ZValOH (12) was dissolved in DCM (40 
mL). The mixture was cooled to 0 °C, and DCC (4.13 g, 20.0 mmol, 1 equiv.) in DCM (40 mL) 
was added to give a white suspension. Methyl 2-amino-3-(1H-indol-2-yl)propanoate (11) (4.56 g, 
20.0 mmol, 1 equiv.) was added in a DCM solution (40 mL), the reaction was stirred at 0 °C for 
an hour, then the ice bath was removed. After stirring overnight a white suspension was obtained. 
The suspension was filtered through Celite, and the resulting solution was concentrated under 
vacuum, to give a white solid. The solid was purified by column chromatography (200 g SiO2, 
hex:EtOAc 1:1), to give a white solid (~9 g).The crude product was recrystallized from MeOH 
(15 mL), and washed with MeOH (4 mL), to give a solid, that was dried on high vac. for several 
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hours (7.9 g yield). To obtain a pure product a second recrystallization was necessary to yield 
peptide 4a (4.3 g, 9.5 mmol, 48% yield) as a white solid, after drying in high vacuum. 
Rf: 0.40 (hex:EtOAc 2:3). 
Mp: 147-149 °C. lit.: 150-151 °C.5 
1H NMR (400 MHz, CDCl3) δ 8.29 (s, 1 H, indole NH), 7.52 (d, 1 H, J = 7.8 Hz, ArH), 7.39-7.26 
(m, 6 H, ArH), 7.18 (t, 1 H, J = 7.1 Hz, ArH), 7.11 (m, 1 H, ArH), 6.91 (s, 1 H, indole C3H), 6.79 
(d, 1 H, J = 7.6 Hz, NH), 5.52 (d, 1 H, J = 9.1 Hz, NH), 5.06 (m, 1 H, CH), 5.00-4.85 (m, 2 H, 
Cbz CH2), 4.25 (dd, 1 H, J = 8.8, 6.0 Hz, CH), 3.67 (s, 3 H, OMe), 3.32 (dd, 1 H, J = 14.8, 5.5 
Hz, CH2), 3.28 (dd, 1 H, J = 15.0, 5.2 Hz, CH2), 2.10 (m, 1 H, Val CH), 0.96 (d, 3 H, J = 6.7 Hz, 
Val Me), 0.90 (d, 3 H, J = 6.7 Hz, Val Me). 
13C NMR (101 MHz, CDCl3) δ 172.1, 171.4, 156.5, 136.3, 136.1, 128.6, 128.1, 127.4, 123.3, 
122.2, 119.6, 118.4, 111.4, 109.3, 67.0, 60.0, 52.8, 52.4, 31.5, 27.6, 19.2, 17.6. 
IR 3407 (w), 3401 (w), 3315 (w), 3314 (w), 3313 (w), 2964 (w), 1711 (m), 1658 (m), 1516 (m), 
1455 (w), 1441 (w), 1344 (w), 1266 (m), 1217 (m), 1100 (w), 1030 (w), 736 (s). 
The 13C NMR data fits the reported data, significant shifts from the reported values were 
observed for the 1H NMR data.5  
(S)-methyl 2-(2-(((benzyloxy)carbonyl)amino)acetamido)-3-(1H-indol-3-yl)propanoate (4b) 
 
ZGlyOH (13) (1.05 g, 5.00 mmol, 1.06 equiv.) and tryptophan ester 11 (1.20 g, 4.71 mmol, 1 
equiv.) were dissolved in DCM (50 mL). Diisopropylethyl amine (2.2 mL, 12 mmol, 2.5 equiv.) 
and HOBt (0.766 g, 5.00 mmol, 1.06 equiv.) were added. The reaction mixture was cooled to 0 
°C, and EDC (0.959 g, 5.00 mmol, 1.06 equiv.) was added. The reaction mixture was let to warm 
to room temperature and stirred overnight. The solvent was evaporated under reduced pressure 
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and the resulting thick oil dissolved in ethyl acetate (100 mL). The organic layer was washed 
with 5% KHSO4 (2x20 mL), conc. NaHCO3 (50 mL) and brine (50 mL), dried over MgSO4 and 
the solvent was evaporated under reduced pressure. The crude oil was purified by column 
chromatography (100 g SiO2, hex:EtOAc 1:1) to give peptide 4b (1.85 g, 4.52 mmol, 96% yield) 
as a white amorphous solid, after drying in high vacuo. Compound 4b still contained a small 
amount of impurities (<10%), which were not removed by column chromatography. 
1H NMR (400 MHz, CDCl3) δ 8.19 (br s, 1 H, indole NH), 7.47 (d, 1 H, J = 7.8 Hz, ArH), 7.41-
7.23 (m, 6 H, ArH), 7.15 (m, 1 H, ArH), 7.09 (m, 1 H, ArH), 6.87 (s, 1 H, indole C3H), 6.63 (d, 1 
H, J = 7.7 Hz, NH), 5.44 (m, 1 H, NH), 5.09 (d, 1H, J = 12.3 Hz, Cbz CH2), 5.05 (d, 1H, J = 12.2 
Hz, Cbz CH2), 4.91 (m, 1 H, CH), 3.84-3.72 (m, 2 H, CH2), 3.65 (s, 3 H, OMe), 3.29 (m, 2 H, 
Trp CH2). 
13C NMR (101 MHz, CDCl3) δ 172.1, 168.7, 156.5, 136.1, 136.0, 128.5, 128.2, 128.1, 127.3, 
123.1, 122.1, 119.6, 118.2, 111.3, 109.3, 67.1, 52.7, 52.5, 44.3, 27.4. 
IR 3331 (w), 3062 (w), 2952 (w), 1713 (s), 1668 (s), 1520 (m), 1440 (m), 1345 (m), 1217 (s), 911 
(m), 735 (s). 
HRMS (ESI) calcd. for C22H24N3O5
+ [M+H]+ 410.1710; found 410.1731. 
(S)-Methyl 2-((S)-2-(((benzyloxy)carbonyl)amino)-3-phenylpropanamido)-3-(1H-indol-3-
yl)propanoate (4c) 
 
In a 250 mL round bottomed flask, ZPheOH (14) (1.49 g, 5.00 mmol, 1 equiv.) was dissolved in 
dry DCM (50 mL), then 3-(1H-indol-3-yl)-1-methoxy-1-oxopropan-2-aminium chloride (10) 
(1.27 g, 5.00 mmol, 1 equiv.) was added to give a white suspension. DIPEA (2.18 mL, 12.5 
mmol, 2.5 equiv.) was added and the mixture became a colorless solution. HOBT (0.919 g, 6.00 
mmol, 1.2 equiv.) was added, then the mixture was cooled in an ice-bath. Then EDC (1.05 g, 5.50 
mmol, 1.1 equiv.) was added and the reaction mixture was stirred overnight while it was let to 
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warm up to room temperature. The solvent was evaporated under reduced pressure, and the 
residue was dissolved in EtOAc (100 mL). The organic layer was extracted with 5% KHSO4 
(2x20 mL), conc. NaHCO3 (20 mL), brine (50 mL) and dried over MgSO4. The solvent was 
evaporated under reduced pressure, and the resulting oil was purified via column chromatography 
(SiO2, pentane:EtOAc, 1:1), to give peptide 4c (2.30 g, 4.60 mmol, 92% yield) as a white solid. 
Rf= 0.45 (hex:EtOAc 1:1).  
Mp: 130-134 °C.lit 119-120 °C.6 
1H NMR (400 MHz, CDCl3) δ 8.13 (s, 1 H, indole NH), 7.40 (d, 1 H, J = 7.9 Hz, ArH), 7.25 (m, 
12 H, ArH), 7.06 (t, 1 H, J = 7.1, ArH), 6.81 (s, 1 H, indole C3 H), 6.52 (d, 1 H, J = 6.8 Hz, NH), 
5.34 (d, 1 H, J = 7.7 Hz, NH), 4.99 (q, 2 H, J = 1.2 Hz), 4.88 (dt, 1 H, J = 7.7, 5.5 Hz, CH), 4.54 
(m, 1 H, CH), 3.66 (s, 3 H, OMe), 3.27 (dd, 1 H, J = 15.1, 5.5 Hz, CH2), 3.26 (dd, 1 H, J = 14.9, 
5.4 Hz, CH2), 3.02 (m, 2 H, CH2). 
13C NMR (101 MHz, CDCl3) δ 171.8, 170.7, 155.9, 136.3, 136.1, 129.4, 128.7, 128.6, 128.2, 
128.0, 127.4, 127.0, 123.1, 122.2, 119.7, 118.4, 111.4, 109.5, 67.0, 56.0, 53.0, 52.4, 38.5, 27.6. 
One aromatic C is not resolved. 
IR 3409 (w), 3325 (w), 3324 (w), 3323 (w), 3061 (w), 3060 (w), 3033 (w), 2952 (w), 1737 (m), 
1710 (m), 1660 (m), 1659 (m), 1516 (m), 1455 (w), 1440 (w), 1342 (w), 1261 (m), 1214 (m), 
1183 (w), 1182 (w), 1109 (w), 1108 (w), 1048 (w), 1029 (w), 737 (s). 
Significant shifts from the reported values were observed for the 1H NMR data.6  
(S)-methyl 2-((S)-2-(((benzyloxy)carbonyl)amino)-3-(4-hydroxyphenyl)propanamido)-3-
(1H-indol-3-yl)propanoate (4d) 
 
                                                          
6Kolesinska, B.; Kaminski, Z. J. Org. Lett. 2009, 11, 765. 
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Dry DCM (50 mL) was filled into a 100 mL round bottomed flask. The hydrochloride salt 3-(1H-
indol-3-yl)-1-methoxy-1-oxopropan-2-aminium chloride (10) (1.27 g, 5.00 mmol, 1 equiv.) was 
suspended with stirring. 2-(((Benzyloxy)carbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid 
(15) (1.58 g, 5.00 mmol, 1 equiv.) was added. DIPEA (2.18 mL, 12.5 mmol, 2.5 equiv.) was 
added, while the suspension cleared out to give a colorless solution. HOBT (0.766 g, 5.00 mmol, 
1 equiv.) was added. The reaction mixture was cooled in an ice bath and EDC (0.959 g, 5.00 
mmol, 1 equiv.) was added. The reaction mixture was stirred overnight, while it was let to warm 
up to room temperature. The residue was dissolved in EtOAc (100 mL), washed with 5% KHSO4 
(2 x 20 mL), then with conc. NaHCO3 (20 mL) and brine (50 mL). The organic layer was dried 
over MgSO4.The solvent was evaporated under reduced pressure and the residue was purified by 
column chromatography (SiO2, hex:EtOAc, 3:2) to give peptide 4d (1.86 g, 3.61 mmol, 72% 
yield) a white solid. 
Rf = 0.35 (hex:EtOAc 2:3). 
Mp: 79-85 °C lit. 113-116 °C.6 
1H NMR (400 MHz, CDCl3) δ 8.23 (s, 1 H, indole NH), 7.44-7.26 (m, 8 H, ArH), 7.16 (m, 1 H, 
ArH), 7.07 (m, 1 H, ArH), 6.91 (d, 2 H, J = 7.5 Hz, ArH), 6.76 (s, 1 H, ArH), 6.64-6.47 (m, 2 H, 
ArH), 6.37 (d, 1 H, J = 7.2 Hz, NH), 5.45 (d, 1 H, J = 7.9 Hz, NH), 5.09-4.99 (m, 2 H, Cbz CH2), 
4.83 (m, 1 H, CH), 4.38 (m, 1 H, CH), 3.58 (s, 3 H, OMe), 3.23 (m, 2 H, CH2), 2.88 (m, 2 H, 
CH2). 
13C NMR (101 MHz, CDCl3) δ 172.0, 171.5, 156.2, 155.3, 136.1, 136.0, 130.4, 128.6, 128.3, 
128.0, 127.5, 127.3, 123.4, 122.1, 119.6, 118.3, 115.7, 111.5, 109.0, 67.2, 56.3, 53.1, 52.5, 37.9, 
27.5. 
IR 3399 (w), 3384 (w), 3340 (w), 3325 (w), 3057 (w), 3037 (w), 2953 (w), 1707 (m), 1659 (m), 
1616 (w), 1597 (w), 1515 (s), 1454 (m), 1453 (m), 1441 (m), 1342 (w), 1260 (m), 1220 (s), 1178 
(m), 1130 (w), 1105 (w), 1049 (w), 1027 (w), 830 (w), 811 (w), 737 (s). 
Significant shifts from the reported values were observed for the 1H NMR data.6  
(S)-Methyl 2-((S)-2-(((benzyloxy)carbonyl)amino)-3-hydroxypropanamido)-3-(1H-indol-3-
yl)propanoate (4e) 
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3-(1H-indol-3-yl)-1-methoxy-1-oxopropan-2-aminium chloride (10) (2.55 g, 10.0 mmol, 1 
equiv.) was suspended in 100 mL of dry DCM, then 2-(((benzyloxy)carbonyl)amino)-3-
hydroxypropanoic acid (16) (2.39 g, 10.0 mmol, 1 equiv.) was added. N-ethyl-N-
isopropylpropan-2-amine (4.17 mL, 25.0 mmol, 2.5 equiv.) was added and the white solid 
dissolved. HOBT (1.83 g, 12.0 mmol, 1.2 equiv.) was added. The reaction mixture was cooled in 
an ice bath, then EDC (2.11 g, 11.0 mmol, 1.1 equiv.) was added. The resulting solution was 
stirred overnight while it was let to warm to RT. The solvent was evaporated and the resulting 
viscous oil was dissolved in a mixture of EtOAc (200 mL) and DCM (10 mL). The organic layer 
was washed with 5% KHSO4 (2 x 20 mL), conc. NaHCO3 (20 mL), conc. NaCl (50 mL) and 
dried over MgSO4. The solvent was evaporated under reduced pressure. Et2O (50 mL) was added 
into the flask, and evaporated to get a foam, which was dried under vacuum for 1 h (3.6 g, white 
solid). The crude product was purified via column chromatogaraphy (SiO2, hexane: ethyl acetate 
2:8), to get peptide 4e (2.54 g, 5.78 mmol, 58% yield) as a white solid. 
Rf: 0.25 (Hex/EtOAc 1/4).  
Mp: 60-62 °C. lit. 99-100 °C.7 
1H NMR (400 MHz, CDCl3) δ 8.31 (s, 1 H, indole NH), 7.51 (d, 1 H, J = 7.8 Hz, ArH), 7.40-7.24 
(m, 5 H, ArH), 7.21-7.06 (m, 3 H, ArH and OH), 6.93 (d, 1 H, J = 2.3 Hz, ArH), 5.87 (d, 1 H, J = 
7.7 Hz, NH), 5.05 (m, 2 H, Cbz CH2), 4.90 (m, 1 H, CH), 4.25 (br s, 1 H, NH), 3.90 (m, 1 H, 
CH), 3.70 (s, 3 H, OMe), 3.58 (m, 1 H), 3.36-3.20 (m, 3 H). 
13C NMR (101 MHz, CDCl3) δ 172.4, 170.7, 156.5, 136.1, 128.6, 128.3, 128.1, 127.3, 123.2, 
122.2, 119.6, 118.3, 111.5, 109.3, 67.2, 62.9, 55.6, 53.0, 52.7, 27.2. One aromatic C is not 
resolved. 
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IR 3401 (w), 3400 (w), 3379 (w), 3378 (w), 3377 (w), 3337 (w), 3332 (w), 3331 (w), 3330 (w), 
3059 (w), 3058 (w), 2953 (w), 1721 (m), 1714 (m), 1713 (m), 1662 (m), 1517 (m), 1455 (w), 
1440 (w), 1403 (w), 1391 (w), 1342 (w), 1264 (m), 1216 (m), 1183 (w), 1060 (m), 1059 (m), 
1028 (w), 1027 (w), 736 (s). 
Significant shifts from the reported values were observed for the 1H NMR data.7 
(S)-Benzyl 2-(((S)-3-(1H-indol-3-yl)-1-methoxy-1-oxopropan-2-yl)carbamoyl)pyrrolidine-1-
carboxylate (4f) 
 
3-(1H-indol-3-yl)-1-methoxy-1-oxopropan-2-aminium chloride (10) (1.27 g, 5.00 mmol, 1 
equiv.) was suspended in 50 mL of dry DCM, then amino acid 17 (1.25 g, 5.00 mmol, 1 equiv.) 
was added. N-ethyl-N-isopropylpropan-2-amine (2.1 mL, 12 mmol, 2.5 equiv.) was added and 
the white solid dissolved. HOBT (0.92 g, 6.0 mmol, 1.2 equiv.) was added. The reaction mixture 
was cooled in an ice bath, then EDC (1.05 g, 5.50 mmol, 1.1 equiv.) was added. The resulting 
solution was stirred overnight while it was let to warm to RT. The solvent was evaporated and the 
resulting viscous oil was dissolved in EtOAc (100 mL). The organic layer was washed with 5% 
KHSO4 (2 x 20 mL), conc. NaHCO3 (20 mL), conc. NaCl (50 mL) and dried over MgSO4. The 
solvent was evaporated under reduced pressure. The crude product was purified via column 
chromatography (SiO2, hexane: ethyl acetate 2:8), to get peptide 4f (1.98 g, 4.40 mmol, 88% 
yield) as an oil. 
Rf: 0.45 (Hex/EtOAc 1/4).  
1H NMR (400 MHz, CDCl3) δ 8.30-7.96 (br s, 1 H, indole NH), 7.54-7.46 (m, 1 H, ArH), 7.37-
7.27 (m, 5 H, ArH), 7.22-6.94 (m, 3 H, ArH), 6.83 (s, 0.5 H, rotamer 1), 6.37 (s, 0.5 H, rotamer 
2), 5.21-4.96 (m, 2 H, Cbz CH2), 4.93-4.83 (m, 1 H), 4.41-4.16 (m, 1 H), 3.76-3.56 (m, 3 H), 
3.53-3.12 (m, 4 H), 2.42-1.29 (m, 4 H). Broadening of all peaks was observed due to rotamers. 
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IR 3321 (w), 3058 (w), 2953 (w), 1742 (m), 1673 (s), 1519 (m), 1421 (s), 1357 (s), 1211 (s), 
1119 (m), 741 (s). 
1H NMR data is in agreement with the reported data.8 
(S)-Methyl 2-((S)-2-(((benzyloxy)carbonyl)amino)-3-(1H-indol-3-yl)propanamido)-3-
methylbutanoate (4g) 
 
DCM (100 mL) was added to 2-(((benzyloxy)carbonyl)amino)-3-(1H-indol-3-yl)propanoic acid 
(18) (3.38 g, 10.0 mmol, 1 equiv.) and (S)-valine methylester hydrochloride (19) (1.536 g, 10.00 
mmol, 1 equiv.). Then DIPEA (4.37 mL, 25.0 mmol, 2.5 equiv.) was added, and the reaction 
mixture became a colorless solution. HOBT (1.53 g, 10.0 mmol, 1 equiv.) was added. The 
reaction mixture was cooled in an ice-bath, then EDC (1.92 g, 10.0 mmol, 1 equiv.) was added. 
The resulting solution was stirred overnight while it was let to warm to RT and stirred over the 
weekend, shielded from light. The solvent was evaporated under reduced pressure, and the 
resulting thick oil was taken up into EtOAc (450 mL). The solution was washed with 5% KHSO4 
(2x50 mL), conc. NaHCO3 (50 mL), and brine (50 mL). The organic layer was dried over 
MgSO4, and the solvent was evaporated under reduced pressure. The crude oil was purified by 
column chromatography (100 g SiO2, hex/EtOAc 1:1), to give peptide 4g (3.90 g, 8.64 mmol, 
86% yield), as a white solid. 
Mp: 60-66 °C. 
1H NMR (400 MHz, CDCl3) δ 8.10 (s, 1 H, indole NH), 7.71 (d, 1 H, J = 7.1 Hz, ArH), 7.41-7.27 
(m, 6 H, ArH), 7.22 (m, 1 H, ArH), 7.11 (m, 2 H, ArH), 6.16 (d, 1 H, J = 7.7 Hz, NH), 5.55 (d, 1 
H, J = 6.7 Hz, NH), 5.15 (s, 2 H, Cbz CH2), 4.55 (m, 1 H, CH), 4.41 (dd, 1 H, J = 8.4, 5.0 Hz, 
CH), 3.66 (s, 3 H, OMe), 3.35 (dd, 1 H, J = 14.4, 4.8 Hz, CH2), 3.20 (dd, 1 H, J = 14.5, 8.0 Hz, 
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CH2), 2.03 (m, 1 H, Val CH), 0.78 (d, 3 H, J = 6.8 Hz, Val CH3), 0.74 (d, 3 H, J = 6.9 Hz, Val 
CH3). 
13C NMR (101 MHz, CDCl3) δ 171.7, 171.1, 156.0, 136.3, 128.6, 128.2, 128.1, 127.4, 123.4, 
122.4, 119.9, 118.9, 111.2, 110.5, 67.1, 57.4, 55.6, 52.1, 31.2, 28.6, 18.7, 17.8. One aromatic 
carbon is not resolved. 
IR 3323 (w), 3059 (w), 2964 (w), 1708 (s), 1663 (s), 1532 (s), 1455 (m), 1344 (m), 1268 (s), 
1219 (s), 1146 (m), 1024 (m), 742 (s). 
HRMS (ESI) calcd for C25H30N3O5
+ [M+H]+ 452.2180; found 452.2214. 
(5S, 8S, 11S)-Methyl 8-((1H-indol-3-yl)methyl)-5,11-diisopropyl-3,6,9-trioxo-1-phenyl-2-
oxa-4,7,10-triazadodecan-12-oate (4h) 
 
The starting peptide 4g (2.25 g, 5.00 mmol, 1 equiv.) and Pd/C (dry, 10% W%, Degussa 
E105CA/W, 532 mg, 0.500 mmol, 0.1 equiv.) were added into a dry 25 mL round bottomed 
flask. The atmosphere was changed to N2 by evacuating and refilling with nitrogen 3 times. 50 
mL of dry MeOH was added. H2 was bubbled through the solution with strong stirring for 20 
minutes, at which time TLC did not show the starting material (Rf(SM)= 0.30 Hex/EtOAc 1/1), 
but only one spot that is not moving even in hex/EtOAc 2/3. Celite was added, then the reaction 
mixture was filtered through a plug of celite. The solvent was evaporated to give a colorless oil. 
The residue was dissolved in Et2O (50 mL) to give an opaque solution. 3N HCl in CPME (2 mL) 
was added with stirring to form a slowly solidifying oil. The solvent was evaporated under 
reduced pressure, and Et2O (20 mL) was added, and evaporated under reduced pressure, to give 
peptide 20 (1.70 g, 4.80 mmol, 96% yield) as a white solid, which was use directly without 
further purification. 
(S)-2-(((benzyloxy)carbonyl)amino)-3-methylbutanoic acid (12) (263 mg, 1.04 mmol, 1.1 equiv.) 
and peptide 20 (336 mg, 0.950 mmol, 1 equiv.) were stirred in DCM (10 mL) to give a white 
S15 
 
suspension. DIPEA (0.415 mL, 2.37 mmol, 2.5 equiv.) was added in one portion to give a 
colorless solution. HOBT (306 mg, 1.99 mmol, 2.1 equiv.) was added, then the solution was 
cooled to 0 °C in an ice-bath. After 10 min., EDC (364 mg, 1.90 mmol, 2 equiv.) was added. The 
resulting solution was stirred overnight, while it was let to warm up to RT. A suspension is 
formed. The solvent was removed under reduced pressure, and the crude was dissolved in EtOAc 
(100 mL). The organic layer was washed with 5% KHSO4 (2x20 mL), conc. NaHCO3 (20 mL), 
and brine (50 mL). The solution was dried over MgSO4, and the solvent was evaporated under 
reduced pressure. The product was purified by column chromatography (SiO2, hex/EtOAc2/1) to 
give peptide 4h (86.0 mg, 0.156 mmol, 16% yield) as an amorphous solid. 
Rf = 0.40 (hex/EtOAc 3/2). 
1H NMR (400 MHz, DMSO) δ 10.80 (s, 1 H, indole NH), 8.15 (d, 1 H, J = 8.1 Hz, ArH or NH), 
8.01 (d, 1 H, J = 8.1 Hz, ArH or NH), 7.56 (d, 1 H, J = 7.8 Hz, Ar H or NH), 7.38-7.20 (m, 5 H, 
ArH), 7.30 (d, J = 7.9 Hz, ArH or NH), 7.22, (d, 1 H, J = 9.0 Hz, ArH or NH), 7.14 (d, 1 H, J = 
1.7 Hz, ArH), 7.04 (t, 1 H, J = 7.1 Hz, ArH), 6.96 (t, 1 H, J = 7.3 Hz, ArH), 5.04 (d, 1 H, J = 12.7 
Hz, Cbz CH2), 5.00 (d, 1 H, J = 12.6 Hz, Cbz CH2), 4.69 (dd, 1 H, J = 13.8, 7.9 Hz, CH), 4.16 
(dd, 1 H, J = 7.9, 6.6 Hz, CH), 3.86 (dd, 1 H, J = 8.7, 7.2 Hz, CH), 3.59 (s, 3 H, OMe), 3.08 (dd, 
1 H,  J = 14.8, 5.6 Hz, CH2-tryptophan), 2.94 (dd, 1 H, J = 14.8, 8.3 Hz, CH2-tryptophan), 2.04-
1.95 (m, 1 H, Val CH), 1.89 (m, 1 H, Val CH), 0.85 (d, 3 H,  J = 6.8 Hz, Val Me), 0.84 (d, 3 H, 
 J = 6.8 Hz, Val Me), 0.76 (d, 6 H,  J = 6.7 Hz, Val Me).  
13C NMR (101 MHz, DMSO) δ 171.7, 171.7, 170.9, 156.0, 137.0, 136.0, 128.3, 127.7, 127.6, 
127.3, 123.5, 120.8, 118.4, 118.1, 111.1, 109.8, 65.4, 60.2, 57.4, 54.9, 52.8, 51.6, 30.4, 29.9, 
27.7, 19.1, 18.9, 18.2. 
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4. Alkynylation of Peptides 
4.1 General Procedure 
 
The starting peptide 4 (0.20 mmol, 1 equiv.) and TIPS-EBX (1a) (0.240 mmol, 103 mg, 1.2 
equiv.) were added into a 5 mL test-tube equipped with a stirring bar. Acetonitrile (2 mL) was 
added, then the reaction mixture was stirred at 40 °C for 2 min. Gold(I) chloride (2.3 mg, 10 
µmol, 0.05 equiv.) was added in one portion. The reaction was sealed and stirred for 24 h at 40 
°C. The mixture was diluted with EtOAc (50 mL), and the organic layer was washed with a 
mixture of water (2.5 mL) and conc. NaHCO3 solution (2.5 mL), and then with brine (20 mL), 
and dried over MgSO4. The solvent was evaporated under reduced pressure and the resulting 
yellow oil was purified by column chromatography (SiO2, hexane:EtOAc 3:1 to 2:3). The product 
was dried under reduced pressure, and washed into a vial with Et2O. The solvent was evaporated 
under vacuum and dried under high vacuum (~10-2 mbar) for several hours. 
4.2. Scope of the Alkynylation of Peptides 
(S)-methyl 2-((S)-2-(((benzyloxy)carbonyl)amino)-3-methylbutanamido)-3-(2-
((triisopropylsilyl)ethynyl)-1H-indol-3-yl)propanoate (5a) 
 
Starting from peptide 4a (90 mg, 0.20 mmol) alkyne 5a (98.1 mg, 0.155 mmol, 78% yield) was 
obtained as a white solid. 
Rf: 0.80 (hex:EtOAc 2:3).  
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Mp: 70-73 °C. 
1H NMR (400 MHz, CDCl3) δ 8.16 (s, 1 H, indole NH), 7.59 (d, 1 H, J = 7.9 Hz, ArH), 7.40-7.21 
(m, 7 H, ArH), 7.13 (t, 1 H, J = 7.5 Hz, ArH), 6.25 (d, 1 H, J = 6.9 Hz, NH), 5.32 (d, 1 H, J = 8.6 
Hz, NH), 5.08 (s, 2 H, Cbz CH2), 4.83 (dd, 1 H, J = 7.2, 7.2 Hz, CH), 4.02 (dd, 1 H, J = 8.4, 5.3 
Hz, CH), 3.69 (s, 3 H, OMe), 3.37 (dd, 1 H, J = 14.3, 6.1 Hz, Trp CH2), 3.31 (dd, 1 H, J = 14.2, 
7.8 Hz, Trp CH2), 2.06 (m, 1 H, Val CH), 1.17 (m, 21 H, TIPS), 0.92 (d, 3 H, J = 6.7 Hz, Val 
Me), 0.81 (d, 3 H, J = 6.7 Hz, Val Me). 
13C NMR (101 MHz, CDCl3) δ 171.9, 170.7, 156.1, 136.3, 135.6, 128.5, 128.1, 128.1, 126.7, 
124.2, 120.7, 119.1, 118.1, 116.7, 111.1, 98.6, 97.4, 66.9, 59.8, 53.1, 52.5, 31.7, 19.0, 18.7, 17.3, 
11.3. 
IR 3411 (w), 3410 (w), 3407 (w), 3406 (w), 3318 (w), 3317 (w), 3316 (w), 3062 (w), 2945 (m), 
2892 (w), 2866 (m), 2146 (w), 1729 (s), 1713 (s), 1663 (s), 1511 (s), 1505 (s), 1460 (m), 1440 
(m), 1369 (m), 1348 (m), 1279 (m), 1278 (m), 1217 (s), 1180 (m), 1025 (m), 998 (m), 883 (m), 
741 (s), 722 (s). 
HRMS (ESI) calcd for C36H50N3O5Si
+ [M+H]+ 632.3514; found 632.3502. 
(S)-methyl 2-(2-(((benzyloxy)carbonyl)amino)acetamido)-3-(2-((triisopropylsilyl)ethynyl)-
1H-indol-3-yl)propanoate (5b) 
 
Starting from peptide 4b (82 mg, 0.20 mmol) alkyne 5b (77 mg, 0.13 mmol, 66% yield) was 
obtained as an oil. 
1H NMR (400 MHz, CDCl3) δ 8.16 (s, 1 H, indole NH), 7.54 (d, 1 H, J = 7.9 Hz, ArH), 7.41-7.16 
(m, 7 H, ArH), 7.13 (m, 1 H, ArH), 6.35 (d, 1 H, J = 7.2 Hz, NH), 5.30 (br s, 1 H, NH), 5.30 (s, 2 
H, Cbz CH2), 4.88 (dd, 1 H, J = 6.7, 6.7 Hz, CH), 3.84 (m, 2 H, CH2), 3.69 (s, 3 H, OMe), 3.36 
(m, 2H, Trp CH2), 1.21-1.08 (m, 21 H, TIPS). 
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13C NMR (101 MHz, CDCl3) δ 171.9, 168.2, 156.2, 136.3, 135.6, 128.6, 128.2, 128.1, 126.8, 
124.2, 120.6, 119.0, 118.2, 116.6, 111.1, 98.5, 97.6, 67.1, 53.0, 52.6, 44.2, 28.0, 18.7, 11.3. 
IR 3320 (w), 3062 (w), 2948 (m), 2867 (w), 2146 (w), 1730 (s), 1674 (s), 1516 (s), 1446 (m), 
1352 (m), 1221 (s), 1051 (w), 997 (m), 883 (w), 741 (s). 
HRMS (ESI) calcd for C33H44N3O5Si
+ [M+H]+ 590.3045; found 590.3041. 
(S)-Methyl 2-((S)-2-(((benzyloxy)carbonyl)amino)-3-phenylpropanamido)-3-(2-
((triisopropylsilyl)ethynyl)-1H-indol-3-yl)propanoate (5c) 
 
Starting from peptide 4c (100 mg, 0.200 mmol) alkyne 5c (86.5 mg, 0.127 mmol, 64% yield) was 
obtained as a white solid. 
Rf: 0.70 (hex:EtOAc 2:3).  
Mp: 65-71 °C. 
1H NMR (400 MHz, CDCl3) δ 8.09 (s, 1 H, indole NH), 7.45-7.05 (m, 14 H, ArH), 6.21 (d, 1 
H, J = 7.2 Hz, NH), 5.24 (d, 1 H, J = 7.2 Hz, NH), 5.05 (s, 2 H, Cbz CH2), 4.82 (dd, 1 H, J = 6.8, 
6.8 Hz, CH), 4.37 (m, 1 H, CH), 3.67 (s, 3 H, OMe), 3.32-3.24 (m, 2 H), 3.00 (dd, 1 H, J = 13.7, 
7.0 Hz, CH2), 2.93 (dd, 1 H, J = 13.2, 5.6 Hz, CH2), 1.32-1.07 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 171.6, 170.2, 156.0, 136.3, 135.5, 129.4, 128.5, 128.5, 128.1, 
128.0, 127.0, 126.9, 124.1, 120.6, 119.1, 118.1, 116.7, 111.1, 98.5, 97.3, 66.8, 56.0, 53.0, 52.5, 
38.7, 28.2, 18.7, 11.3. One aromatic carbon did not resolve 
IR 3408 (w), 3407 (w), 3406 (w), 3405 (w), 3399 (w), 3399 (w), 3398 (w), 3335 (w), 3323 (w), 
3320 (w), 3062 (w), 3061 (w), 3032 (w), 2945 (w), 2892 (w), 2865 (w), 2146 (w), 1727 (m), 
1668 (m), 1499 (m), 1455 (m), 1454 (m), 1439 (m), 1366 (w), 1347 (w), 1245 (m), 1244 (m), 
1215 (m), 1181 (w), 1180 (w), 1120 (w), 1047 (w), 1032 (w), 1031 (w), 998 (w), 883 (w), 739 
(s). 
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HRMS (ESI) calcd. for C40H50N3O5Si
+ [M+H]+ 680.3514; found 680.3501. 
(S)-Methyl 2-((S)-2-(((benzyloxy)carbonyl)amino)-3-(4-hydroxyphenyl)propanamido)-3-(2-
((triisopropylsilyl)ethynyl)-1H-indol-3-yl)propanoate (5d)  
 
Starting from peptide 4d (103 mg, 0.200 mmol) alkyne 5d (93.1 mg, 0.134 mmol, 67% yield) 
was obtained as a slightly yellow solid. 
Rf: 0.65 (hex:EtOAc 2:3).  
Mp: 85-89 °C. 
1H NMR (400 MHz, CDCl3) δ 8.16 (s, 1 H, indole NH), 7.44-7.19 (m, 8 H, ArH), 7.08 (t, 1 
H, J = 7.4 Hz, ArH), 6.96 (d, 2 H, J = 7.5 Hz, ArH), 6.57 (d, 2 H, J = 7.8 Hz, ArH), 6.13 (d, 1 
H, J = 7.1 Hz, NH), 5.32 (m, 1 H, NH), 5.07 (s, 2 H, Cbz CH2), 4.80 (dd, 1 H, J = 6.6, 6.6 Hz, 
CH), 4.31 (m, 1 H, CH), 3.68 (s, 3 H, OMe), 3.29 (d, 2 H, J = 6.3 Hz, CH2), 2.87 (br d, 2 H, J = 
6.3 Hz, CH2), 1.32-1.05 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 171.6, 170.4, 155.6, 154.5, 136.3, 135.5, 130.6, 128.5, 128.2, 
128.0, 126.9, 124.1, 120.6, 119.0, 118.2, 116.4, 115.4, 111.1, 98.6, 97.2, 66.9, 56.3, 53.0, 52.5, 
38.1, 27.9, 18.7, 11.3. One aromatic carbon is not resolved. 
IR 3388 (m), 3387 (m), 3384 (m), 3383 (m), 3382 (m), 3381 (m), 3380 (m), 3379 (m), 3345 (m), 
3345 (m), 3344 (m), 3343 (m), 3342 (m), 3341 (m), 3340 (m), 2947 (m), 2946 (m), 2866 (w), 
2865 (w), 2147 (w), 1723 (s), 1670 (s), 1669 (s), 1613 (w), 1516 (s), 1515 (s), 1451 (m), 1354 
(m), 1353 (m), 1352 (m), 1228 (s), 1117 (w), 1116 (w), 1054 (w), 1053 (w), 1022 (w), 1021 (w), 
885 (w), 835 (w), 834 (w), 833 (w), 742 (m), 741 (m). 
HRMS (ESI) calcd. for C40H50N3O6Si
+ [M+H]+ 696.3463; found 696.3462. 
(S)-Methyl 2-((S)-2-(((benzyloxy)carbonyl)amino)-3-hydroxypropanamido)-3-(2-
((triisopropylsilyl)ethynyl)-1H-indol-3-yl)propanoate (5e)  
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Starting from peptide 4e (88 mg, 0.20 mmol) alkyne 5e (79.1 mg, 0.128 mmol, 64% yield) was 
obtained as a white solid. 
Rf: 0.60 (hex:EtOAc 2:3).  
Mp: 65-67 °C. 
1H NMR (400 MHz, CDCl3) δ 8.15 (s, 1 H, indole NH), 7.50 (d, 1 H, J = 8.0 Hz, ArH), 7.38-7.20 
(m, 7 H, ArH), 7.12 (m, 1 H, ArH), 6.73 (d, 1 H, J = 7.5 Hz, NH), 5.57 (d, 1 H, J = 7.4 Hz, NH), 
5.06 (s, 2 H, Cbz CH2), 4.88 (m, 1 H, CH), 4.17 (m, 1 H, CH), 3.91 (m, 1 H, CH2O), 3.71 (s, 3 H, 
OMe), 3.51 (m, 1 H, CH2O), 3.40 (dd, 1 H, J = 14.4, 5.8 Hz, CH2), 3.31 (dd, 1 H, J = 14.4, 7.7 
Hz, CH2), 2.79 (t, 1 H, J = 6.9 Hz, OH), 1.37-0.97 (m, 21 H, TIPS). 
13C NMR (101 MHz, CDCl3) δ 172.4, 170.5, 156.0, 136.2, 135.5, 128.6, 128.3, 128.1, 126.7, 
124.2, 120.6, 118.9, 118.3, 116.5, 111.2, 99.0, 97.3, 67.1, 63.3, 55.5, 53.3, 52.9, 27.5, 18.7, 11.3. 
IR 3398 (m), 3322 (m), 3321 (m), 3320 (m), 3319 (m), 3062 (w), 3061 (w), 2947 (m), 2946 (m), 
2893 (w), 2892 (w), 2866 (m), 2865 (m), 2147 (w), 1724 (s), 1723 (s), 1669 (s), 1511 (s), 1505 
(s), 1504 (s), 1460 (m), 1455 (m), 1350 (m), 1221 (s), 1118 (w), 1063 (m), 1021 (m), 884 (m), 
742 (s), 727 (s), 726 (s). 
HRMS (ESI) calcd. for C34H46N3O6Si
+ [M+H]+ 620.3150; found 620.3146. 
(S)-Benzyl 2-(((S)-1-methoxy-1-oxo-3-(2-((triisopropylsilyl)ethynyl)-1H-indol-3-yl)propan-2-
yl)carbamoyl)pyrrolidine-1-carboxylate (5f)  
 
S21 
 
Starting from peptide 4f (90 mg, 0.20 mmol) alkyne 5f (66.5 mg, 0.106 mmol, 53% yield) was 
obtained as a white solid. 
Rf=0.30 (hex/EtOAc 3/2).  
Mp: 58-68 °C. 
1H NMR (400 MHz, CDCl3) δ 8.09 (s, 1 H, indole NH), 7.55-7.49 (m, 1 H, ArH), 7.37-6.98 (m, 8 
H, ArH), 6.40 (br s, 0.5 H, NH rotamer 1), 5.22-5.02 (m, 1.5 H, NH), 5.10 (s, 1 H, Cbz CH2 
rotamer 1), 5.10 (s, 1 H, Cbz CH2 rotamer 2), 4.99-4.77 (m, 1 H, CH), 4.29 (br s, 0.5 H, CH, 
rotamer 1), 4.22 (br s, 0.5 H, CH, rotamer 2), 3.64 (s, 1.5 H, OMe, rotamer 1), 3.62 (s, 1.5 H, 
OMe, rotamer 2), 3.46-3.12 (m, 4 H, CH2), 2.32-1.38 (m, 4 H, CH2), 1.40-0.88 (m, 21 H, TIPS). 
Broad peaks were observed due to the presence of rotamers. Rotamers are not specifically 
assigned. 
13C NMR (101 MHz, CDCl3) δ 172.1, 172.0, 171.4, 155.9, 155.0, 136.6, 135.5, 128.5, 128.0, 
127.9, 127.1, 124.1, 123.9, 121.5, 120.7, 120.5, 120.4, 119.3, 119.3, 119.1, 119.0, 118.1, 117.4, 
117.1, 110.9, 110.9, 98.5, 97.5, 97.4, 67.2, 60.8, 60.5, 53.1, 52.9, 52.4, 47.4, 46.9, 30.8, 28.4, 
28.0, 24.3, 23.4, 18.7, 11.3. Due to the presence of rotamers, not all peaks can be resolved. 
IR 3327 (w), 3307 (w), 3302 (w), 3301 (w), 3300 (w), 2946 (w), 2945 (w), 2889 (w), 2865 (w), 
2250 (w), 2146 (w), 1743 (m), 1688 (m), 1687 (m), 1517 (w), 1437 (m), 1436 (m), 1414 (m), 
1353 (m), 1280 (w), 1242 (w), 1241 (w), 1212 (m), 1211 (m), 1181 (m), 1180 (m), 1119 (m), 
1090 (w), 994 (w), 913 (s), 883 (m), 738 (s). 
HRMS (ESI) calcd for C36H48N3O5Si
+ [M+H]+ 630.3358; found 630.3343. 
(5S,8S,11S)-Methyl 5,11-diisopropyl-3,6,9-trioxo-1-phenyl-8-((2-((triisopropylsilyl)ethynyl)-
1H-indol-3-yl)methyl)-2-oxa-4,7,10-triazadodecan-12-oate (5h)  
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Starting from peptide 4h (86 mg, 0.16 mmol) alkyne 5h (57 mg, 0.078 mmol, 50% yield) was 
obtained as a white solid. 
Rf= 0.75 (hex/EtOAc 2:3). 
Mp 77-79 °C. 
1H NMR (400 MHz, CDCl3) δ 8.09 (s, 1 H, indole NH), 7.63 (d, 1 H, J = 8.0 Hz, ArH), 7.42-7.29 
(m, 5 H, ArH), 7.26-7.17 (m, 2 H, ArH), 7.11 (m, 1 H, ArH), 6.50 (d, 1 H, J = 7.1 Hz, NH), 6.23 
(d, 1 H, J = 8.4 Hz, NH), 5.16 (d, 1 H, J = 8.1 Hz, NH), 5.08 (m, 2 H, Cbz CH2), 4.69 (dd, 1 
H, J = 7.6, 7.6 Hz, CH), 4.41 (dd, 1 H, J = 8.3, 5.1 Hz, CH), 4.01 (m, 1 H, CH), 3.60 (s, 3 H, 
OMe), 3.30 (d, 2 H, J = 7.7 Hz, CH2), 2.04 (m, 2 H, Val CH), 1.21-1.03 (m, 21 H, TIPS), 0.86 (d, 
3 H, J = 6.8 Hz, Val CH3), 0.81 (d, 3 H, J = 7.8 Hz, Val CH3), 0.80 (d, 3 H, J = 7.4 Hz, Val CH3), 
0.68 (d, 3 H, J = 6.6 Hz, Val CH3). 
13C NMR (101 MHz, CDCl3) δ 171.4, 171.1, 170.5, 156.2, 136.3, 135.7, 128.6, 128.3, 128.1, 
126.8, 124.2, 120.6, 119.2, 118.2, 117.3, 111.0, 98.8, 97.3, 67.1, 60.2, 57.4, 54.0, 52.0, 31.6, 
31.2, 27.9, 19.1, 18.7, 17.9, 17.1, 11.3. One valine CH3 is not resolved. 
IR 3313 (m), 3063 (w), 2957 (m), 2868 (w), 2146 (w), 1708 (m), 1656 (s), 1515 (s), 1462 (m), 
1346 (w), 1233 (m), 1146 (w), 1027 (w), 884 (w), 742 (s). 
HRMS (ESI) calcd. for C41H59N4O6Si
+ [M+H]+ 731.4198; found 731.4190. 
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5. NMR Spectra of New compounds  
 
1HNMR, 400 MHz, CDCl3 
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13CNMR, 100 MHz, CDCl3 
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13HNMR, 100 MHz, DMSO-d6 
1HNMR, 400 MHz, DMSO-d6 
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